A U.K. study found that people who took aspirin or nonsteroidal anti-inflammatory drugs, such as ibuprofen, at least once in the past year were 36% less prone to developing cancer in the lower or middle portion of the stomach. Study authors also noted that their findings did not demonstrate a reduction in the risk of upper-stomach cancer. An expert said more trials are needed to weigh the benefits and adverse effects of using such drugs to prevent the condition.

Full Story:

Related Summaries